BRUKER CORPORATION
Bruker Corporation is a publicly traded life-science and diagnostics instrumentation company listed on the Nasdaq Global Select Market under the ticker BRKR, with its Series A Mandatory Convertible Preferred Stock trading separately under ticker BRKRP. The company is a Delaware corporation — originally formed in Massachusetts in 1991 as Bruker Federal Systems Corporation and reincorporated in Delaware in 2000 — and its principal executive offices are at 40 Manning Road, Billerica, Massachusetts, the same Billerica address reflected in this registry’s records. Separately, Bruker Corporation is registered with the California Secretary of State (registration number 2224633, status: active) as a corporation authorised to transact business in that state.
Bruker Corporation designs, manufactures and services scientific and analytical instruments for life-science research, applied and industrial markets, and clinical diagnostics. Its reported segments are BSI BioSpin (nuclear magnetic resonance, electron paramagnetic resonance and preclinical imaging systems), BSI CALID (mass spectrometry, microbiology and infectious-disease diagnostics, and optical spectroscopy), BSI NANO (nanoscale instrumentation such as atomic force microscopy and X-ray systems) and Bruker Energy & Supercon Technologies (superconducting materials and magnet systems). Customers include academic, pharmaceutical, biotechnology, clinical, food-safety, forensic and industrial laboratories worldwide.
For the fiscal year ended 31 December 2025, the company reported consolidated revenue of approximately 3.44 billion US dollars, up 2.1% from 3.37 billion US dollars in fiscal year 2024, according to its fourth-quarter and full-year 2025 results announcement. Recent developments include the completed asset acquisition of the NanoString Technologies business (closed 6 May 2024, approximately 392.6 million US dollars), now operated within the company’s Spatial Biology unit, and the acquisitions of the ELITechGroup in-vitro diagnostics business (2024) and Recipe Chemicals + Instruments GmbH (2025).
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Shareholders
5
Bruker Corporation is a public company on the Nasdaq Global Select Market, so its shareholder base is disclosed through beneficial-ownership filings with the U.S. Securities and Exchange Commission rather than published as a complete shareholder register. Based on the company’s definitive proxy statement for its 2026 annual meeting (record date 1 April 2026, with 152,223,137 shares of common stock outstanding), the largest disclosed institutional holders were FMR LLC (17,082,320 shares, 11.2%), Orbis Investment Management Ltd (15,197,866 shares, 10.0%) and BlackRock, Inc. (9,822,776 shares, 6.5%). These are aggregate reportable positions across each investor’s affiliated funds and accounts, not single registered shareholders of record, and the underlying holdings may have changed since the filing date.
Ultimate beneficial ownership
The largest individual beneficial owner on record is Frank H. Laukien, Bruker Corporation’s Chairman, President and Chief Executive Officer, who beneficially owned 40,510,066 shares (26.6% of common stock) as of 1 April 2026. This figure includes options exercisable within 60 days and shares held by family members over whom he is reported to exercise voting influence, although he disclaims beneficial ownership of those family holdings. The interest is held directly and personally rather than through a disclosed intermediate holding company, so no further ownership chain applies above this level.
Data availability
Availability here is best described as major shareholders only: SEC rules require only holders of 5% or more of the company’s stock, together with directors and executive officers, to report beneficial ownership, so the full base of smaller institutional and retail shareholders is not itemised publicly. Percentages reflect each filer’s most recently reported position and are not necessarily contemporaneous with one another.
Sources
- Bruker Corporation, Definitive Proxy Statement (Schedule DEF 14A) for the 2026 Annual Meeting of Shareholders — SEC EDGAR, filed 10 April 2026, retrieved 11 September 2026.
| Shareholder | Type | Holding | Source Document |
|---|---|---|---|
| T. Rowe Price Investment Management, Inc. | 0.2% | California Secretary of State — bizfile Online | |
| Blackrock Inc. | 0.2% | California Secretary of State — bizfile Online | |
| iShares Trust-iShares Preferred and Income Securities ETF | 0.2% | California Secretary of State — bizfile Online | |
| Jain Global LLC | 0.1% | California Secretary of State — bizfile Online | |
| VanEck ETF Trust-VanEck Preferred Securities ex Financials ETF | 0.1% | California Secretary of State — bizfile Online |
Officers
5
Bruker Corporation discloses its current executive officers through SEC filings and investor-relations materials. Separately, each U.S. state in which the company is registered to do business collects its own officer listing as part of routine corporate filings, which is why registry data can show a large number of officer records for a single company across many states. Based on the company’s own disclosures, Frank H. Laukien is Chairman, President and Chief Executive Officer, a role he has held since Bruker’s founding era in the early 1990s. Gerald N. Herman has served as Executive Vice President and Chief Financial Officer since June 2018, having joined the company in 2016 as Vice President and Corporate Controller. Patrick Minhorst is recorded as the company’s Treasurer in state corporate filings, including with the Nevada Secretary of State, and separately holds the role of Vice President of Finance within the company’s Bruker BioSpin business.
Additional names appear in state-level officer filings for the company beyond this verified set; their current roles and appointment dates could not be independently corroborated against a primary source within this review and are therefore not described here.
Data availability
U.S. state corporate registries generally record officers as of the company’s most recent annual or franchise-tax filing rather than in real time, and do not disclose nationality or country of residence for corporate officers. The company’s own SEC filings and proxy statements are the more current and complete source for its senior executive team.
Sources
- Bruker Corporation — Bruker Corporation Appoints Gerald Herman as Chief Financial Officer, press release, 2018 — ir.bruker.com, retrieved 11 September 2026.
- Bruker Corporation, Form 10-K for fiscal year 2025 — SEC EDGAR, filed 27 February 2026, retrieved 11 September 2026.
Group Structure
Bruker Corporation is a publicly traded Delaware corporation and, per its own SEC filings, has no parent company; it is the ultimate parent of the wider Bruker corporate group. The group is organised around four reporting segments (BSI BioSpin, BSI CALID, BSI NANO and Bruker Energy & Supercon Technologies) and operates through numerous subsidiaries across North America, Europe and Asia. One long-standing, independently verifiable subsidiary is Bruker BioSpin Corporation (Massachusetts), which became part of the group when Bruker Corporation and Bruker BioSpin combined under common ownership in a transaction that closed on 26 February 2008.
The company has continued to expand the group through acquisitions in recent years, including the ELITechGroup in-vitro diagnostics business (2024), an asset acquisition of the NanoString Technologies business completed 6 May 2024 for approximately 392.6 million US dollars (now operated within the company’s Spatial Biology unit), and Recipe Chemicals + Instruments GmbH (2025). These transactions are confirmed by the company’s own announcements and SEC filings, though this review did not independently re-verify the registration number, exact ownership percentage or current legal status of every operating entity that these acquisitions brought into the group.
Verified corporate relationships
| Entity | Country | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|
| Bruker BioSpin Corporation | United States (Massachusetts) | Direct subsidiary (combined under common control) | Ownership percentage not disclosed | Active | 26 Feb 2008 (transaction date) |
Data availability
Group-structure information for Bruker Corporation is partial: the company confirms it has no parent, and its major, publicly announced subsidiaries and acquisitions are traceable through SEC filings and company announcements. However, Bruker Corporation does not publish a complete, ownership-percentage-by-entity subsidiary register, and the fuller list of smaller operating subsidiaries that can appear in third-party corporate-linkage data was not independently re-verified against each country’s primary company registry within this review.
Sources
- Bruker Corporation — Bruker Completes Asset Acquisition of NanoString Business, press release, 6 May 2024 — ir.bruker.com, retrieved 11 September 2026.
- Bruker Corporation, Form 10-K for fiscal year 2025 — SEC EDGAR, filed 27 February 2026, retrieved 11 September 2026.
Bruker Corporation
United States
Get complete shareholder and officer records, ultimate beneficial owner resolution, and ongoing ownership monitoring.
Frequently Asked Questions
What does BRUKER CORPORATION do?
Bruker Corporation is a Nasdaq-listed (BRKR) scientific instrumentation company producing NMR, mass spectrometry, X-ray and microbiology-diagnostics systems for life-science, applied and clinical markets, with consolidated revenue of approximately 3.44 billion US dollars in fiscal year 2025.
Who owns BRUKER CORPORATION?
As a US public company, the largest disclosed 5%-plus holders as of 1 April 2026 were FMR LLC (11.2%), Orbis Investment Management Ltd (10.0%) and BlackRock, Inc. (6.5%); the wider retail and institutional shareholder base is not itemised publicly.
Who is BRUKER CORPORATION's UBO (Ultimate Beneficial Owner)?
Frank H. Laukien, Chairman, President and CEO of Bruker Corporation, beneficially owned 26.6% of common stock as of 1 April 2026, making him the largest individual beneficial owner on record.
What is BRUKER CORPORATION's company registration number?
BRUKER CORPORATION's registration number is 2224633, filed with California Secretary of State — bizfile Online in United States. Its current status on the register is active.
Is BRUKER CORPORATION still an active company?
BRUKER CORPORATION's status on California Secretary of State — bizfile Online is listed as active.
When was BRUKER CORPORATION incorporated?
BRUKER CORPORATION was incorporated on 20 March 2000, according to California Secretary of State — bizfile Online.
What is BRUKER CORPORATION's registered address?
The registered address on file for BRUKER CORPORATION is BILLERICA, United States.
What is BRUKER CORPORATION's revenue?
Fiscal year 2025 consolidated revenue was approximately 3.44 billion US dollars, up 2.1% from 3.37 billion US dollars in fiscal year 2024.
Is BRUKER CORPORATION listed on a stock exchange?
Common stock trades on the Nasdaq Global Select Market under ticker BRKR; Series A Mandatory Convertible Preferred Stock trades under ticker BRKRP.
Who are the officers/directors of BRUKER CORPORATION?
Verified current officers include Frank H. Laukien (Chairman, President and CEO), Gerald N. Herman (EVP and CFO since 2018) and Patrick Minhorst (Treasurer).
Does BRUKER CORPORATION have a parent company or subsidiaries?
Bruker Corporation is the ultimate parent of the Bruker group and has no parent company; a verified subsidiary is Bruker BioSpin Corporation, and recent group acquisitions include ELITechGroup and the NanoString Technologies business (2024).
Can Zavia monitor changes to BRUKER CORPORATION's ownership over time?
This profile reflects a point-in-time snapshot from California Secretary of State — bizfile Online. Zavia's monitoring API can track changes to BRUKER CORPORATION's registered shareholders, officers, and group structure going forward, flagging updates as they're filed rather than requiring a manual recheck.
Can I access BRUKER CORPORATION's data through an API?
Yes. Zavia's API connects directly to official government ownership registries across 195 countries and territories, including United States, so records like BRUKER CORPORATION's registration, shareholder, UBO, and group-structure data can be queried programmatically instead of viewed one page at a time.
Where does this company information come from, and how current is it?
This record is sourced directly from California Secretary of State — bizfile Online and was last synced on 9 September 2026.